Query author contributions in Reactome

Reactome depends on collaboration between our curation team and outside experts to assemble and peer-review its pathway modules. The integration of ORCID within Reactome enables us to meet a key challenge with authoring, curating and reviewing biological information by incentivizing and crediting the external experts that contribute their expertise and time to the Reactome curation process. More information is available at ORCID and Reactome.

If you have an ORCID ID that is not listed on this page, please forward this information to us and we will update your Reactome pathway records.

Details on Person Haferlach, Torsten

Class:Id	Person:8865898
_displayName	Haferlach, Torsten
_timestamp	2016-03-28 13:08:00
created	[InstanceEdit:8865900] May, Bruce, 2016-03-28
firstname	Torsten
initial	T
surname	Haferlach
(author)	[LiteratureReference:8865904] Aberrant splicing of U12-type introns is the hallmark of ZRSR2 mutant myelodysplastic syndrome [LiteratureReference:9691821] Identification of a novel type of ITD mutations located in nonjuxtamembrane domains of the FLT3 tyrosine kinase receptor [LiteratureReference:9692388] Selective BCL-2 inhibition by ABT-199 causes on-target cell death in acute myeloid leukemia [LiteratureReference:9703277] Response of ETV6-FLT3-positive myeloid/lymphoid neoplasm with eosinophilia to inhibitors of FMS-like tyrosine kinase 3 [LiteratureReference:9988467] Molecular and clinical analyses of PHF6 mutant myeloid neoplasia provide their pathogenesis and therapeutic targeting
[Change default viewing format]

No pathways have been reviewed or authored by Haferlach, Torsten (8865898)